Grufity logo
Grufity logo
QNCX

QNCX - Quince Therapeutics, Inc. Stock Price, Fair Value and News

$23.67+0.64 (+2.78%)
Market Closed as of 31 Jul 2026, 04:00 pm ET

Price Targets

QNCX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

QNCX Price Action

Last 7 days

32.6%

Last 30 days

41.3%

Last 90 days

1679.7%

Trailing 12 Months

40.1%

QNCX RSI Chart

QNCX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

QNCX Valuation

Market Cap

385.8M

Price/Earnings (Trailing)

-11.68

EV/EBITDA

-3.39

Price/Free Cashflow

-9.73

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

QNCX Fundamentals

QNCX Earnings

Earnings (TTM)

-33.0M

Earnings Growth (Yr)

338.94%

Earnings Growth (Qtr)

191.01%

QNCX Profitability

Return on Equity

-210.8%

Return on Assets

-124.09%

Free Cashflow Yield

-10.28%

QNCX Investor Care

Shares Dilution (1Y)

270.97%

Diluted EPS (TTM)

-10.56

Revenue & Growth

How Quince Therapeutics, Inc. generates revenue and covers its expenses, based on the latest reported earnings.

About Quince Therapeutics, Inc.

QNCX
Quince Therapeutics, Inc., a preclinical stage biopharmaceutical company, develops precision therapeutics for debilitating and rare diseases. Its lead compound is NOV004, a systemically administered bone anabolic peptide engineered to target and concentrate at bone fracture sites. The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.
 CEO
 WEBSITEquincetx.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES21

Quince Therapeutics, Inc. Frequently Asked Questions

QNCX is the stock ticker symbol of Quince Therapeutics, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Jul 31 2026, market cap of Quince Therapeutics, Inc. is 385.84 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.